Search Results - "Pérez‐Alvarez, N."

Variable endothelial cell function restoration after initiation of two antiretroviral regimens in HIV-infected individuals by Echeverría, P, Gómez-Mora, E, Roura, S, Bonjoch, A, Puig, J, Pérez-Alvarez, N, Bayés-Genís, A, Clotet, B, Blanco, J, Negredo, E

“…The effect of ART on endothelial cell function is incompletely characterized. We performed a 24 week prospective, case-control and comparative pilot study of…”
Get full text

Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa ®), in antiretroviral-naïve patients: A 48-week, multicentre, randomized study (Lake Study) by Echeverría, P., Negredo, E., Carosi, G., Gálvez, J., Gómez, J.L., Ocampo, A., Portilla, J., Prieto, A., López, J.C., Rubio, R., Mariño, A., Pedrol, E., Viladés, C., del Arco, A., Moreno, A., Bravo, I., López-Blazquez, R., Pérez-Alvarez, N., Clotet, B.

“…Although efavirenz and lopinavir/ritonavir(r) are both recommended antiretroviral agents in antiretroviral-naïve HIV-infected patients, there are few…”
Get full text

Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV‐1‐infected patients with multidrug‐resistant virus: a multicentre pilot study by Llibre, JM, Bonjoch, A, Iribarren, J, Galindo, MJ, Negredo, E, Domingo, P, Pérez‐Alvarez, N, Martinez‐Picado, J, Schapiro, J, Clotet, B

“…Objectives To evaluate the safety, immunological outcome and HIV‐1 evolution in the reverse transcriptase (RT) in patients with multidrug resistance receiving…”
Get full text

Hill A, Moyle G. Relative antiviral efficacy of ritonavir‐boosted darunavir and ritonavir‐boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trials. HIV Med 2007; 8: 259–264 by Llibre, JM, Pérez‐Alvarez, N

Get full text

Comparison of two different strategies of treatment with zoledronate in HIV‐infected patients with low bone mineral density: single dose versus two doses in 2 years by Negredo, E, Bonjoch, A, Pérez‐Álvarez, N, Ornelas, A, Puig, J, Herrero, C, Estany, C, Río, L, Gregorio, S, Echeverría, P, Clotet, B

“…Objectives Given the need for easily managed treatment of osteoporosis in HIV‐infected patients, we evaluated the efficacy and tolerability of two doses of…”
Get full text

Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients by Fumaz, C. R., Muñoz-Moreno, J. A., Ballesteros, A. L., Paredes, R., Ferrer, M. J., Salas, A., Fuster, D., Masmitjà, E., Pérez-Álvarez, N., Gómez, G., Tural, C., Clotet, B.

“…This is a prospective observational comparative 48-week study to assess the impact of the different types of Peg-IFN on depressive and neuropsychiatric…”
Get full text

Adherence and health beliefs in a psychoeducative intervention in naïve HIV‐1‐infected men: the PROADH study by Fumaz, C, Muñoz‐Moreno, J, Ferrer, M, Gonzalez‐Garcia, M, Perez‐Alvarez, N, Miranda, C, Negredo, E, Clotet, B

“…Background Health beliefs are an important factor in the maintenance of an adherent behaviour. However, specific interventions based on the modification of…”
Get full text

Aging‐associated symptoms in the physician‐patient dialogue in a group of long‐term diagnosed HIV‐infected individuals by Fumaz, C, Muñoz‐Moreno, J, Ferrer, M, Gonzalez‐Garcia, M, Perez‐Alvarez, N, Negredo, E, Chamorro, A, Clotet, B

“…Background The significant decrease in mortality has resulted in a large number of individuals aged over 50 living with HIV infection. Additionally, the…”
Get full text

Prevalence of cardiovascular risk factors in Spanish HIV‐1‐infected male inmates by Golf, JP, Sala, L, Aramburo, J, Sardà, P, Perez‐Alvarez, N, Llibre, JM

“…7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK…”
Get full text

Hill A, Moyle G. Relative antiviral efficacy of ritonavir-boosted darunavir and ritonavir-boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trials. HIV Med 2007; 8: 259-264. Methodological accuracy in cross-trial comparisons of antiretroviral regimens in multitreated patients by Llibre, J M, Pérez-Alvarez, N

Get full text

Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiated by Bonjoch, A, Buzon, M J, Llibre, J M, Negredo, E, Puig, J, Pérez-Alvarez, N, Videla, S, Martinez-Picado, J, Clotet, B

“…We determined whether coformulated zidovudine/lamivudine/abacavir plus tenofovir could maintain immune status in comparison with a genotype-guided salvage…”
Get more information

PRS16 Cost Analysis of Haemostatic Treatment with a Fibrin-Based Sponge Versus Fibrin Sealant in Lung Surgery and Liver Resection in a Spanish Setting by Darba, J, Kaskens, L, Perez-Alvarez, N

Get full text

PSY8 Neuropathic Pain: a Budget Impact Analysis to Estimate Costs Due to the Introduction of Qutenza® on the Spanish Market by Darba, J, Kaskens, L, Perez-Alvarez, N

Get full text

PIH35 Disability-Adjusted-Life-Years (DALYs) Loss in Postmenopausal Women with Osteoporosis by Darba, J, Kaskens, L, Perez-alvarez, N, Palacios, S, Neyro, J.L, Rejas, J

Get full text

Condylomata, cytological abnormalities and human papillomavirus infection in the anal canal in HIV‐infected men by Darwich, L, Cañadas, MP, Videla, S, Coll, J, Piñol, M, Cobarsi, P, Molina‐López, RA, Vela, S, García‐Cuyás, F, Llatjos, M, Sirera, G, Clotet, B, Fernández, I., Castella, E., LLatjós, M., Bonjoch, A., Echevarría, P., Jabaloyas, M., Jou, A., Llibre, J. M., Moltó, J., Negredo, E., Pérez‐Alvarez, N., Rey‐Joly, C., Romeu, J., Santos, J. R., Tural, C., Alcalde, C., Guerola, R., Salas, A., Castilla, I., Cirigliano, V., Ejarque, M., López, E., Ordóñez, E., Rueda, L.

“…Background Genital infections with low‐risk (LR) and high‐risk (HR) human papillomavirus (HPV) genotypes are associated with ano‐genital condylomata and anal…”
Get full text

Long-Term Neuropsychiatric Disorders on Efavirenz-Based Approaches: Quality of Life, Psychologic Issues, and Adherence by Fumaz, Carmina R, Munoz-Moreno, Jose A, Moltó, José, Negredo, Eugènia, Ferrer, Maria José, Sirera, Guillem, Pérez-Alvarez, Núria, Gómez, Guadalupe, Burger, David, Clotet, Bonaventura

“…BACKGROUND:Efavirenz has been associated with neuropsychiatric disorders, although little is known about its long-term toxicity. OBJECTIVE:To assess…”
Get full text

PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase: Five-Years Follow-up Simulated Cohort by Darba, J, Perez-Alvarez, N, Kaskens, L, Martin, P

Get full text

CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART by MASSANELLA, Marta, NEGREDO, Eugenia, PEREZ-ALVAREZ, Nuria, PUIG, Jordi, RUIZ-HERNANDEZ, Raul, BOFILL, Margarita, CLOTET, Bonaventura, BLANCO, Julià

“…The failure to increase CD4 T-cell counts in some HAART-treated HIV-infected patients with satisfactory virological responses has been related to low CD4…”
Get full text

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study by BONJOCH, Anna, FIGUERAS, Marta, NEGREDO, Eugènia, ESTANY, Carla, PEREZ-ALVAREZ, Núria, ROSALES, Joaquim, DEL RIO, Luís, DI GREGORIO, Silvana, PUIG, Jordi, GOMEZ, Guadalupe, CLOTET, Bonaventura

“…Low bone mineral density (BMD) is an emerging metabolic condition in HIV-infected patients; however, data on progression of this disease are scarce. We studied…”
Get full text

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV-Infected Patients: Clinical Implications by Negredo, Eugènia, Massanella, Marta, Puig, Jordi, Pérez-Álvarez, Núria, Gallego-Escuredo, José Miguel, Villarroya, Joan, Villarroya, Francesc, Molto, José, Santos, Jose Ramón, Clotet, Bonaventura, Blanco, Julià

“…Background. Although antiretroviral therapy improves immune response, some human immunodeficiency virus-infected patients present unsatisfactory CD4 T cell…”
Get full text